Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lobular Carcinoma In Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Temporarily pausedNCT03077841
What this trial is testing

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituEarly-Stage Breast CarcinomaInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 928
Large-scale testing (Phase 3)Study completedNCT00003857
What this trial is testing

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 636
Testing effectiveness (Phase 2)Looking for participantsNCT06540872
What this trial is testing

Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer

Who this might be right for
Carcinoma, Intraductal, Noninfiltrating
Universität Münster 30
Testing effectiveness (Phase 2)Study completedNCT02526498
What this trial is testing

Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor PositiveInvasive Breast Carcinoma+4 more
Rutgers, The State University of New Jersey 200
Early research (Phase 1)Study completedNCT00290732
What this trial is testing

Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableActive Not RecruitingNCT01644669
What this trial is testing

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

Who this might be right for
Invasive Ductal CarcinomaDuctal Carcinoma in Situ
Xoft, Inc. 1,200
Testing effectiveness (Phase 2)Study completedNCT02637024
What this trial is testing

Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation

Who this might be right for
Breast CancerDCIS
Ontario Clinical Oncology Group (OCOG) 280
Not applicableActive Not RecruitingNCT05410951
What this trial is testing

LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients

Who this might be right for
Lobular Breast CarcinomaLobular in Situ Breast CarcinomaBRCA1 Mutation+1 more
European Institute of Oncology 800
Not applicableEnded earlyNCT03505372
What this trial is testing

Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia

Who this might be right for
Atypical Ductal Hyperplasia
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT00764322
What this trial is testing

Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen

Who this might be right for
Breast CancerMenopausal Symptoms
UNC Lineberger Comprehensive Cancer Center 501
Early research (Phase 1)Study completedNCT00749437
What this trial is testing

Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
University of Medicine and Dentistry of New Jersey 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT01245712
What this trial is testing

Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer

Who this might be right for
Breast AdenocarcinomaDuctal Breast Carcinoma In SituInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 200
Not applicableStudy completedNCT06133647
What this trial is testing

Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System

Who this might be right for
Ductal Carcinoma in SituInvasive Lobular Breast Carcinoma
Methodist Health System 8
Not applicableLooking for participantsNCT07292246
What this trial is testing

A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)

Who this might be right for
Breast CancerBRCA 1 Gene MutationBRCA 2 Gene Mutation+5 more
Vasileios Kalles 15
Not applicableStudy completedNCT03669952
What this trial is testing

Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer

Who this might be right for
Outcome of Breast Cancer
Omphis Foundation 464
Not applicableUnknownNCT05868252
What this trial is testing

Molecular Analysis of the Sloane Project

Who this might be right for
DCISLCISAtypical Ductal Hyperplasia+1 more
King's College London 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT02750826
What this trial is testing

Breast Cancer WEight Loss Study (BWEL Study)

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaStage II Breast Cancer AJCC v6 and v7+4 more
Alliance for Clinical Trials in Oncology 3,177
Not applicableStudy completedNCT00959244
What this trial is testing

Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105

Who this might be right for
Breast Cancer
University of Nebraska 100
Testing effectiveness (Phase 2)Ended earlyNCT02137252
What this trial is testing

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Who this might be right for
Invasive Breast Cancer (Stage I-III)Ductal Carcinoma in SituLobular Carcinoma in Situ+2 more
Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT01849250
What this trial is testing

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

Who this might be right for
Benign Breast NeoplasmDuctal Breast Carcinoma In SituInvasive Breast Carcinoma+9 more
National Cancer Institute (NCI) 65
Next Page